Citadel Advisors’s ArriVent BioPharma AVBP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$733K	Buy	+33,655	New	+$733K	﹤0.01%	3631
2024 Q2	–	Sell	-286,512	Closed	-$5.12M	–	6950
2024 Q1	$5.12M	Buy	+286,512	New	+$5.12M	﹤0.01%	1736